周三，减肥药概念集体走强， STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD 涨超5%， 此前GPCR公布其每日一次、口服小分子GLP-1受体激动剂aleniglipron在ACCESS临床项目中取得积极顶线结果。同时，诺和诺德 涨超4%， 罗氏控股 涨超3%， 礼来 跟涨。
周三，减肥药概念集体走强， STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD 涨超5%， 此前GPCR公布其每日一次、口服小分子GLP-1受体激动剂aleniglipron在ACCESS临床项目中取得积极顶线结果。同时，诺和诺德 涨超4%， 罗氏控股 涨超3%， 礼来 跟涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
